Optofluidics Awarded NIH Phase II SBIR
Read more here
News
Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER
Read more here
HealthQx Partners with Leader in Value-based Payment Reform
Read more here
Relmada Announces the Filing of Clinical Trial Application in Canada for D-Methadone
Read more here
Novira Therapeutics Announces Successful Completion of Phase 1a Clinical Study of NVR-1221 and Commencement of Phase 1b Clinical Studies
Read more here
Galleon Pharmaceuticals Announces Publication of Proof-of-Concept Clinical Studies for GAL-021, Projected Use for the Emerging Perioperative Sleep Apnea Epidemic
Read more here
Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board
Read more here
Relmada Therapeutics, Inc. Completes Name Change and Announces New Ticker
Read more here
Optofluidics Awarded NSF Phase IIB SBIR
Read more here
Intezyne Technologies Expands Executive Leadership Team with Two Key Appointments
Read more here